Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

JPMorgan 3-Year NDX/RTY/SPX Barrier Notes, CUSIP 46661QHN8

JPMorgan Chase Financial Company LLC filed a free writing prospectus (FWP) under Rule 433 disclosing the preliminary terms of its 3-Year Uncapped Accelerated Barrier Notes linked to the Nasdaq-100, Russell 2000, and S&P 500 indexes, with a pricing date of November 30, 2026.

Nitish Kishor | 04 November 2026

JPMorgan 5yr EFA/SX5E Barrier Notes Priced Dec 2026

JPMorgan Chase Financial Company LLC filed a free writing prospectus (FWP) on November 4, 2026, disclosing the preliminary terms of 5-year Uncapped Accelerated Barrier Notes linked to the iShares MSCI EAFE ETF and the EURO STOXX 50 Index, with a pricing date of November …

Shwetambri Chauhan | 04 November 2026

Lake Superior Acquisition Revises OMG Merger Terms, Extends Deadline

Lake Superior Acquisition Corp. filed an 8-K on November 4, 2026, disclosing that on November 3, 2026, it entered into an Amended and Restated Agreement and Plan of Merger and Business Combination Agreement with Openmarkets Group Pty Ltd and related parties, revising the structure …

Vinay Lochav | 04 November 2026

JPMorgan 5yr RTY/SPX Barrier Notes Priced Nov 30, 2026

JPMorgan Chase Financial Company LLC filed a free writing prospectus (FWP) under Rule 433 disclosing the preliminary terms of its 5-Year Russell 2000/S&P 500 Uncapped Accelerated Barrier Notes, with a scheduled pricing date of November 30, 2026.

Manish Choudhary | 04 November 2026

JPMorgan 5yr NDX/RTY/SPX Barrier Notes Priced Nov 30 2026

JPMorgan Chase Financial Company LLC filed a free writing prospectus (FWP) under Rule 433 disclosing the preliminary terms of its 5-year Uncapped Accelerated Barrier Notes linked to the Nasdaq-100 Index, Russell 2000 Index, and S&P 500 Index, with a pricing date of November 30, …

Manish Choudhary | 04 November 2026

JPMorgan 5yr EFA/SX5E Barrier Notes Priced Nov 24 2026

JPMorgan Chase Financial Company LLC filed a free writing prospectus on November 4, 2026, disclosing the preliminary terms of 5-year Uncapped Accelerated Barrier Notes linked to the iShares MSCI EAFE ETF and the EURO STOXX 50 Index, with a pricing date of November 24, …

Nitish Kishor | 04 November 2026

BioAdaptives to Acquire Xycota Biosciences in All-Stock Deal

BioAdaptives, Inc. filed a Form 8-K on November 4, 2026, disclosing that on October 29, 2026, it entered into a Membership Interest Purchase Agreement to acquire 100% of the membership interests of Xycota Biosciences LLC, a preclinical CNS biotechnology company.

Aakashdeep | 04 November 2026

Bio-Techne Announces Cash Dividend, November 3, 2026

Bio-Techne Corporation filed a Form 8-K with the SEC on November 3, 2026, disclosing the issuance of a press release announcing a cash dividend.

Anjali Anand | 04 November 2026

ArcBest Files 8-K for Q3 2026 Earnings Release

ArcBest Corporation filed a Form 8-K with the SEC on November 4, 2026, reporting the issuance of a press release announcing its unaudited third quarter 2026 financial results, along with supplemental information and earnings conference call presentation slides.

Aakashdeep | 04 November 2026

Addentax to Acquire Double Cash Finance via 464,907-Share Deal

Addentax Group Corp. filed a Form 8-K on November 4, 2026, disclosing that it entered into a Share Exchange Agreement on November 3, 2026, under which its subsidiary Yingxi Industrial Chain Investment Co., Ltd. will acquire 100% of Double Cash Finance Limited in exchange …

Anjali Anand | 04 November 2026
Support

Hi! How can we help you today?

Loading…